April 21, 2026
Law360 Healthcare Authority looks at the U.S. Supreme Court's rejection of a petition by Johnson & Johnson challenging the certification of an investor class, a Pennsylvania state court's recognition of a constitutional right to "reproductive autonomy" and other court rulings affecting the industry this week.
April 20, 2026
The U.S. Supreme Court on Monday said it won't review a class certification challenge in a securities class action over Johnson & Johnson's cancer-related talc products in the latest development in a closely watched dispute over how courts evaluate class certification in shareholder suits.
March 23, 2026
Four groups of amici have urged the U.S. Supreme Court to take up Johnson & Johnson's challenge to a Third Circuit decision allowing a securities class action over its talc products to proceed, warning the ruling could reshape how shareholder suits are litigated nationwide.